Midwest Trust Co Makes New $3.16 Million Investment in Colgate-Palmolive Company $CL

Midwest Trust Co purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 34,795 shares of the company’s stock, valued at approximately $3,163,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Flossbach Von Storch SE grew its stake in shares of Colgate-Palmolive by 13.1% in the 2nd quarter. Flossbach Von Storch SE now owns 315,928 shares of the company’s stock valued at $28,718,000 after buying an additional 36,592 shares during the period. Acadian Asset Management LLC grew its position in Colgate-Palmolive by 42.9% in the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after acquiring an additional 1,839,853 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Colgate-Palmolive by 6.3% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,631,026 shares of the company’s stock worth $148,260,000 after acquiring an additional 96,128 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Colgate-Palmolive by 62.8% in the second quarter. Parkside Financial Bank & Trust now owns 9,994 shares of the company’s stock valued at $908,000 after purchasing an additional 3,854 shares during the period. Finally, Aviva PLC lifted its stake in shares of Colgate-Palmolive by 90.5% in the 2nd quarter. Aviva PLC now owns 1,948,872 shares of the company’s stock valued at $177,152,000 after purchasing an additional 925,802 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $78.45 on Tuesday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The firm has a market cap of $63.24 billion, a PE ratio of 22.04, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company’s 50 day moving average is $79.62 and its two-hundred day moving average is $85.54.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 earnings per share. On average, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CL. Raymond James Financial cut their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Barclays decreased their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research report on Friday, October 10th. Finally, Citigroup lowered their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Nine research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.